» Articles » PMID: 2233759

Recognition of Imidazole and Histamine Derivatives by Monoclonal Antibodies

Overview
Journal Mol Immunol
Date 1990 Oct 1
PMID 2233759
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The different ways of raising antibodies to histamine are reviewed. High affinity monoclonal antibodies could be raised only against derivatized histamine. Succinyl glycinamide derivatization provided the basis of an efficient radioimmunoassay. In this paper the molecular pattern and the thermodynamical properties of histamine recognition were thoroughly investigated. Only the neutral form and not the cationic form of imidazole was recognized. As expected, the ligand recognition increased, with improved structural homology to the immunogen. However, a detailed analysis revealed a zwitterionic effect whenever a carboxylic group was present on the side chain of the ligand.

Citing Articles

Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib.

Sogawa R, Saita T, Yamamoto Y, Kimura S, Narisawa Y, Kimura S J Pharm Anal. 2019; 9(1):49-54.

PMID: 30740257 PMC: 6355467. DOI: 10.1016/j.jpha.2018.09.002.


Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imaging.

Kim H, Wang X, Wahlberg B, Edwards W Bioconjug Chem. 2014; 25(7):1311-22.

PMID: 24898150 PMC: 4103757. DOI: 10.1021/bc500173f.


Pretargeting: taking an alternate route for localizing radionuclides.

Sharkey R, Chang C, Rossi E, McBride W, Goldenberg D Tumour Biol. 2012; 33(3):591-600.

PMID: 22396041 DOI: 10.1007/s13277-012-0367-6.


Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method.

Schoffelen R, van der Graaf W, Sharkey R, Franssen G, McBride W, Chang C EJNMMI Res. 2012; 2:5.

PMID: 22284761 PMC: 3298693. DOI: 10.1186/2191-219X-2-5.


Pretargeted radioimmunotherapy for hematologic and other malignancies.

Walter R, Press O, Pagel J Cancer Biother Radiopharm. 2010; 25(2):125-42.

PMID: 20423225 PMC: 2936263. DOI: 10.1089/cbr.2010.0759.